Analytical Method Development for Biologics and Bioconjugates

Developing robust analytical methods in the pre-clinical setting is often complicated by limited information about a therapeutic’s properties and indistinct regulatory expectations.

Throughout every stage of therapeutic development – from cell line selection to final release – robust analytical methods are vital to ensuring product quality, de-risking decisions, and meeting regulatory milestones.

Abzena’s integrated approach combines deep scientific expertise with advanced instrumentation to develop, qualify, and validate methods tailored to your molecule’s unique needs.

Learn more by downloading our info sheet today, and contacting our scientific experts.